These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17993370)

  • 21. Gastric cardia inflammation and intestinal metaplasia: associations with reflux esophagitis and Helicobacter pylori.
    Goldstein NS; Karim R
    Mod Pathol; 1999 Nov; 12(11):1017-24. PubMed ID: 10574598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy.
    Johnston MH; Hammond AS; Laskin W; Jones DM
    Am J Gastroenterol; 1996 Aug; 91(8):1507-11. PubMed ID: 8759651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
    El-Zimaity HM; Graham DY
    Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric cardia intestinal metaplasia: biopsy follow-up of 85 patients.
    Goldstein NS
    Mod Pathol; 2000 Oct; 13(10):1072-9. PubMed ID: 11048800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients.
    Yagi K; Nakamura A; Sekine A
    J Gastroenterol Hepatol; 2005 Jun; 20(6):929-34. PubMed ID: 15946143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic versus histological diagnosis of Barrett's esophagus: a cross-sectional survey.
    Irvanloo G; Fallahi B; Ensani F; Azmi M; Morteza A
    Pol J Pathol; 2011 Sep; 62(3):152-6. PubMed ID: 22102072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
    Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
    Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction.
    McIntire MG; Soucy G; Vaughan TL; Shahsafaei A; Odze RD
    Am J Surg Pathol; 2011 Jul; 35(7):1007-13. PubMed ID: 21602660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?
    Morales TG; Bhattacharyya A; Johnson C; Sampliner RE
    Am J Gastroenterol; 1997 Oct; 92(10):1818-22. PubMed ID: 9382043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy.
    Riddell RH
    Am J Surg Pathol; 1996; 20 Suppl 1():S31-50. PubMed ID: 8694147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specialized intestinal metaplasia and carditis at the gastroesophageal junction in Chinese patients undergoing endoscopy.
    Law S; Lam KY; Chu KM; Wong J
    Am J Gastroenterol; 2002 Aug; 97(8):1924-9. PubMed ID: 12190155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology of the gastroesophageal junction.
    Odze RD
    Semin Diagn Pathol; 2005 Nov; 22(4):256-65. PubMed ID: 16939053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrett's esophagus: the long and the short of it.
    Nandurkar S; Talley NJ
    Am J Gastroenterol; 1999 Jan; 94(1):30-40. PubMed ID: 9934728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carditis: all Helicobacter pylori or is there a role for gastro-oesophageal reflux?
    McNamara D; Buckley M; Crotty P; Hall W; O'Sullivan M; O'Morain C
    Scand J Gastroenterol; 2002 Jul; 37(7):772-7. PubMed ID: 12190089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group.
    Voutilainen M; Färkkilä M; Juhola M; Nuorva K; Mauranen K; Mäntynen T; Kunnamo I; Mecklin JP; Sipponen P
    Am J Gastroenterol; 1999 Apr; 94(4):913-8. PubMed ID: 10201456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
    Mohammed IA; Streutker CJ; Riddell RH
    Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?
    Hackelsberger A; Günther T; Schultze V; Manes G; Dominguez-Muñoz JE; Roessner A; Malfertheiner P
    Gut; 1998 Jul; 43(1):17-21. PubMed ID: 9771400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal metaplasia at the esophagogastric junction in Japanese patients without clinical Barrett's esophagus.
    Nakamura M; Kawano T; Endo M; Iwai T
    Am J Gastroenterol; 1999 Nov; 94(11):3145-9. PubMed ID: 10566705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.